These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34597015)

  • 1. A Nanoplatform to Amplify Apoptosis-to-Pyroptosis Immunotherapy via Immunomodulation of Myeloid-Derived Suppressor Cells.
    Zhou S; Shang Q; Ji J; Luan Y
    ACS Appl Mater Interfaces; 2021 Oct; 13(40):47407-47417. PubMed ID: 34597015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Cell-Targeted Photosensitizer and Therapeutic Protein Co-Delivery Nanoplatform Based on a Metal-Organic Framework for Enhanced Synergistic Photodynamic and Protein Therapy.
    Ding L; Lin X; Lin Z; Wu Y; Liu X; Liu J; Wu M; Zhang X; Zeng Y
    ACS Appl Mater Interfaces; 2020 Aug; 12(33):36906-36916. PubMed ID: 32706242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic Photothermal Tumor Immunotherapy by 1-MT Based on Zeolitic Imidazolate Framework-8 with pH-High Sensitivity.
    Su R; Yang Y; Wu H; Liu B; Tian X; Zhou C; Hu Y; Liu T
    Int J Nanomedicine; 2024; 19():8501-8517. PubMed ID: 39185344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acidic Environment-Responsive Metal Organic Framework-Mediated Dihydroartemisinin Delivery for Triggering Production of Reactive Oxygen Species in Drug-Resistant Lung Cancer.
    Yan X; Zhao X; Fan M; Zheng W; Zhu G; Li B; Wang L
    Int J Nanomedicine; 2024; 19():3847-3859. PubMed ID: 38708182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomimetic Nucleation of Metal-Organic Frameworks on Silk Fibroin Nanoparticles for Designing Core-Shell-Structured pH-Responsive Anticancer Drug Carriers.
    Chen Y; Wu H; Yang T; Zhou G; Chen Y; Wang J; Mao C; Yang M
    ACS Appl Mater Interfaces; 2021 Oct; 13(40):47371-47381. PubMed ID: 34582680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoengineering a metal-organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells.
    Fan Q; Zuo J; Tian H; Huang C; Nice EC; Shi Z; Kong Q
    J Exp Clin Cancer Res; 2022 May; 41(1):162. PubMed ID: 35501823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Multi-in-One" Yolk-Shell Structured Nanoplatform Inducing Pyroptosis and Antitumor Immune Response Through Cascade Reactions.
    Wang YY; Li SL; Zhang XY; Jiang FL; Guo QL; Jiang P; Liu Y
    Small; 2024 Jul; 20(30):e2400254. PubMed ID: 38402432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dual-pathway pyroptosis inducer based on Au-Cu
    Yan X; Chen C; Ren Y; Su T; Chen H; Yu D; Huang Y; Chao M; Wu G; Jiang G; Gao F
    Acta Biomater; 2024 Oct; 188():329-343. PubMed ID: 39278301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid-targeted and pH-responsive drug delivery system based on metal-organic frameworks for efficient antitumor therapy.
    Sun Q; Bi H; Wang Z; Li C; Wang X; Xu J; Zhu H; Zhao R; He F; Gai S; Yang P
    Biomaterials; 2019 Dec; 223():119473. PubMed ID: 31499255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-accelerating pyroptosis nanoinducers for promoting image-guided cancer immunotherapy.
    Liu D; Liang M; Tao Y; Liu H; Liu Q; Bing W; Li W; Qi J
    Biomaterials; 2024 Sep; 309():122610. PubMed ID: 38749307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxygen Self-Sufficient Core-Shell Metal-Organic Framework-Based Smart Nanoplatform for Enhanced Synergistic Chemotherapy and Photodynamic Therapy.
    Ren SZ; Wang B; Zhu XH; Zhu D; Liu M; Li SK; Yang YS; Wang ZC; Zhu HL
    ACS Appl Mater Interfaces; 2020 Jun; 12(22):24662-24674. PubMed ID: 32394704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific MOF-based immunotherapeutic nanoplatforms via synergistic tumor cells-targeted treatment and dendritic cells-targeted immunomodulation.
    Zhang H; Zhang J; Li Q; Song A; Tian H; Wang J; Li Z; Luan Y
    Biomaterials; 2020 Jul; 245():119983. PubMed ID: 32229333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metal-Organic Framework-Based Nanovaccine for Relieving Immunosuppressive Tumors via Hindering Efferocytosis of Macrophages and Promoting Pyroptosis and Cuproptosis of Cancer Cells.
    Liu Y; Niu R; Zhang X; Zhang B; Chen X; Guo J; Song S; Wang Y; Zhang H; Zhao Y
    ACS Nano; 2024 May; 18(19):12386-12400. PubMed ID: 38699808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual depletion of myeloid-derived suppressor cells and tumor cells with self-assembled gemcitabine-celecoxib nano-twin drug for cancer chemoimmunotherapy.
    Zhang X; Liang Q; Cao Y; Yang T; An M; Liu Z; Yang J; Liu Y
    J Nanobiotechnology; 2024 Jun; 22(1):319. PubMed ID: 38849938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facile preparation of metal-organic frameworks-based hydrophobic anticancer drug delivery nanoplatform for targeted and enhanced cancer treatment.
    Dong K; Zhang Y; Zhang L; Wang Z; Ren J; Qu X
    Talanta; 2019 Mar; 194():703-708. PubMed ID: 30609594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineralization of pH-Sensitive Doxorubicin Prodrug in ZIF-8 to Enable Targeted Delivery to Solid Tumors.
    Yan J; Liu C; Wu Q; Zhou J; Xu X; Zhang L; Wang D; Yang F; Zhang H
    Anal Chem; 2020 Aug; 92(16):11453-11461. PubMed ID: 32664723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors.
    Shen J; Ma M; Zhang H; Yu H; Xue F; Hao N; Chen H
    ACS Appl Mater Interfaces; 2020 Oct; 12(41):45838-45849. PubMed ID: 32956582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-Modified Erythrocyte Membrane-Cloaked Metal-Organic Framework Nanoparticles for Targeted Antitumor Therapy.
    Lin Y; Zhong Y; Chen Y; Li L; Chen G; Zhang J; Li P; Zhou C; Sun Y; Ma Y; Xie Z; Liao Q
    Mol Pharm; 2020 Sep; 17(9):3328-3341. PubMed ID: 32804508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal-Organic Framework Nanoparticles to Boost Cancer Immunotherapy.
    Cai Z; Xin F; Wei Z; Wu M; Lin X; Du X; Chen G; Zhang D; Zhang Z; Liu X; Yao C
    Adv Healthc Mater; 2020 Jan; 9(1):e1900996. PubMed ID: 31746153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remodeling the tumor microenvironment to improve drug permeation and antitumor effects by co-delivering quercetin and doxorubicin.
    Li M; Yue X; Wang Y; Zhang J; Kan L; Jing Z
    J Mater Chem B; 2019 Dec; 7(47):7619-7626. PubMed ID: 31746936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.